Abstract
17α-hydroxylase deficiency (17α- OHDS) results in decreased production of cortisol and sex steroids and hypokalemia secondary to excess mineralocorticoids. It has long been known that glucocorticoid deficiency is associated with impaired urinary dilution and increased secretion of vasopressin (AVP). On the other hand, chronic hypokalemia is a well-established cause of nephrogenic diabetes insipidus. We evaluated the status of AVP secretion in a patient with 17α-OHDS and in 8 normokalaemic control subjects during hypertonic saline infusion (5% NaCl 0.06 ml.kg.min.120 min). The patient was evaluated on 3 separate occasions: pre-treatment (PT), and daily treatment with 0.375 mg (T1) and 0.5 mg (T2) dexamethasone. Blood was collected for AVP, corticosterone (B), plasma osmolality (pOsm) and electrolyte determination. In the control group plasma AVP levels increased from 0.8±0.1 to 4.1±0.6 pmol/l and pOsm increased from 282±2 to 302±1.5 mosmol/kg. In the patient, plasma AVP levels increased from 9.3 to 12.3; 4.5 to 6.2; and 2.5 to 6.2 pmol/l, and pOsm increased from 282 to 302, from 290 to 307, and from 291 to 311 mosmol/kg during the PT, T1 and T2 conditions, respectively. Serum potassium levels were low (2.6 mmol/l) during PT and reached normal values after treatment. There was a significant negative correlation between plasma AVP and serum potassium levels (r=−0.71; p<0.001). The results originally indicate that high plasma AVP levels may be found in 17α-OHDS, suggesting an effect of F deficiency per se. In addition, a concealed partial nephrogenic diabetes insipidus secondary to chronic hypokalemia cannot be excluded.
Similar content being viewed by others
References
Biglieri E.G., Herron M.A., Brust N. 17α-hydroxylase deficiency in man. J. Clin. Invest. 1966, 45: 1946–1954.
Moreira A.C., Leal Â.M.O., Castro M. Characterization of adrenocorticotropin secretion in a patient with 17α-hydroxylase deficiency. J. Clin. Endocrinol Metab. 1990, 71: 86–91.
Boykin J., DeTorrenté A., Erickson A., Robertson G., Schrier R.W. Role of plasma vasopressin in impaired water excretion of glucocorticoid deficiency. J. Clin. Invest. 1978, 62: 738–744.
Linas S.L., Berl T., Robertson G.L., Aisenbrey G.A., Schrier R.W., Anderson R.J. Role of vasopressin in the impaired water excretion of glucocorticoid deficiency. Kidney Intern. 1980, 18: 58–67.
Mandell I.N., DeFronzo R.A., Robertson G.L., Forrest J.N. Jr. Role of plasma arginine vasopressine in the impaired water diuresis of isolated glucocorticoid deficiency in the rat. Kidney Intern. 1980, 17: 186–195.
Aguilera G., Lightman S.L., Kiss A. Regulation of the hypothalamic- pituitary-adrenal axis during water deprivation. Endocrinology 1993, 132: 241–248.
Hollander W. Jr., Winters R.W., Williams T.F., Bradley J., Oliver J. Welt L.G. Defect in the renal tubular reabsortion of water associated with potassium depletion in rats. Am. J. Physiol. 1957, 189: 557–563.
Oliver J., MacDowell M., Welt L.G., et al. The renal lesions of electrolyte imbalance. J. Experiment. Med. 1957, 106: 563–574.
Relman A.S., Schwartz W.B. The kidney in potassium depletion. Am. J. Med. 1958, 24: 764–773.
Giebisch G., Lozano R., Maceo A. The effects of adrenal steroids and potassium depletion on the elaboration of an osmotically concentrated urine. J. Clin. Invest. 1959, 38: 843–853.
Manitius A., Levitin H., Beck D., Epstein F.H. On the mechanism of impairment of renal concentrating ability in potassium deficiency. J. Clin. Invest. 1960, 39: 684–692.
Rubini M.E. Water excretion in potassium-deficient man. J. Clin. Invest. 1961, 40: 2215–2224.
Elias L.L.K., Antunes-Rodrigues J., Elias P.C.L., Moreira A.C. Effect of plasma osmolality on pituitary-adrenal responses to corticotropin-releasing hormone and atrial natriuretic peptide changes in central diabetes insipidus. J. Clin. Endocrinol. Metab. 1997, 82: 1243–1247.
López-Jimenez M., Valença M.M., Moreira A.C., Antunes-Rodrigues J. Ether and immobilization, stress effects on pituitary-adrenal function in hemidecorticated rats. Braz. J. Med. Biol. Res. 1989, 22: 779–782.
Dingman J.F., Despointes R.H. Adrenal steroid inhibition of vasopressin release from the neurophysis of normal subjects and patients with Addison’s disease. J. Clin. Invest. 1960, 39: 1851–1863.
Kamoi K., Tamura T., Tanaka K., Ishibashi M., Yamaji T. Hyponatremia and osmoregulation of thirst and vasopressin secretion in patients with adrenal insufficiency. J. Clin. Endocrinol. Metab. 1993, 77: 1584–1588.
Reidenberg M.M., Ohler E.A., Sevy R.W., Harakal C. Hemodynamic changes in adrenalectomized dogs. Endocrinology 1963, 72: 918–923.
Reid I.A., Tu W.H., Otsuka K., Assaykeen T.A., Ganong W.F. Studies concerning the regulation and importance of plasma angiotensinogen concentration in dog. Endocrinology 1973, 93: 107–111.
Salomez-Granier F., Leclerc-Coornaert L., Lefebvre J., Racadot A., Linquette M. Étude de l’hormone antidiurétique (arginine-vasopressine) dans 24 cas d’insuffisance surrénale primitive. Ann. Endocrinol. (Paris) 1983, 44: 371–376.
Rutecki G.W., Cox J.W., Robertson G.W., Francisco L.L., Ferris T.F. Urinary concentrating ability and antidiuretic hormone responsiveness in the potassium-depleted dog. J. Lab. Clin. Med. 1982, 100: 53–60.
Kim J.K., Summer S.N., Berl T. The cyclic AMP system in the inner medullary collecting duct of the potassium-depleted rat. Kidney Intern. 1984, 26: 384–391.
Marples D., Frokiaer J., Dorup J., Knepper M.A., Nielsen S. Hypokalemia-induced down-regulation of aquaporin-2 water channel expression in rat kidney medulla and cortex. J. Clin. Invest. 1996, 97: 1960–1968.
Jespersen B., Danielsen H., Pedersen E.B. Effect of chronic hypokalemia on renal concentration ability and secretion of arginine vasopressin. Scand. J. Clin. Lab. Invest. 1987, 47: 5–9.
Moreira A.C., Leal Â.M.O., Castro M. Adrenocorticotropincorticosterone relationship during dexamethasone therapy in 17α-hydroxylase deficiency. Horm. Metab. Res. 1992, 24: 305–352.
Ma X.M., Levy A., Lightman S.L. Rapid changes of heteronuclear RNA for arginine vasopressin but not for corticotropin-releasing hormone in response to acute corticosterone administration. J. Neuroendocrinol. 1997, 9: 723–728.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Leal, Â.M.O., Elias, P.C.L. & Moreira, A.C. Impairment of AVP regulation in 17α-hydroxylase deficiency, a unique form of adrenal insufficiency. J Endocrinol Invest 25, 635–638 (2002). https://doi.org/10.1007/BF03345089
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03345089